Aleks Radovic-Moreno
Partner @ Longwood Fund
Boston, United States
Aleks Radovic-Moreno is a Series A investor at Longwood Fund in Boston focused on Medical and Life Science. Radovic-Moreno is a Co-Founder of Vor and Vice President at PureTech. He was previously a Research Scientist at the biotech startup AuraSense Therapeutics, where he was a lead inventor of the company's core immunotherapy platform. Dr. Radovic-Moreno completed his graduate work as a NSF Fellow in Robert Langer's lab at MIT, where hedeveloped novel strategies for managing bacterial infections, including a novel vaccine candidate for chlamydia, a disease for which no vaccine currently exists. Dr. Radovic-Moreno was awarded the Alumni Achievement Award by the Pennsylvania State University for extraordinary professional accomplishment by graduates under the age of 35. Dr. Radovic-Moreno received his B.S. in Chemical Engineering from the Pennsylvania State University and PhD in Chemical and Biomedical Engineering from MIT and the Harvard-MIT Division of Health Sciences & Technology.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Aleks Radovic-Moreno invests in
Stages Aleks Radovic-Moreno invests in
Countries Aleks Radovic-Moreno invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Life Science 1 (100%)
- Therapeutics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms. | $65M / Series A / May 14, 2024 |
Co-Investors
About Longwood Fund
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
Longwood Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Aleks Radovic-Moreno
Partner
|
|||
John McCabe
Operating Partner
|
|||
Christoph Westphal
Manager
|
|||
David Donabedian
Executive Partner
|
|||
David Donabedian, PhD
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aleks Radovic-Moreno invest in?
Aleks Radovic-Moreno invests primarily in Medical, Life Science and Therapeutics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aleks Radovic-Moreno?
Public channels for Aleks Radovic-Moreno include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Aleks Radovic-Moreno last invest?
The most recent investment recorded for Aleks Radovic-Moreno closed in May 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
